Related Experiment Video
Updated: Jun 27, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A primer on critical care pharmacy services.
1College of Pharmacy, The University of Arizona, 1295 N. Martin - Pulido, PO Box 210207, Tucson, AZ 85721, USA. erstad@pharmacy.arizona.edu
The Annals of Pharmacotherapy
|November 20, 2008
Summary
Integrating pharmacists into intensive care units (ICUs) improves patient care for critically ill individuals. This paper outlines key considerations for establishing and advancing critical care pharmacy services.
Area of Science:
- Pharmacy Practice
- Critical Care Medicine
- Health Systems Management
Background:
- Intensive care units (ICUs) are central to decentralized pharmacy services due to complex patient needs and high-cost medications.
- Pharmacists are crucial members of interdisciplinary teams in ICUs, evidenced by demonstrated patient care benefits.
Purpose of the Study:
- To outline essential considerations for establishing and developing critical care pharmacy services.
- To guide the progression from basic services to advanced functions like practitioner development and research.
Main Methods:
- This paper reviews key aspects of critical care pharmacy service development.
- It synthesizes information on establishing services, practitioner growth, and implementing guidelines.
Main Results:
- Successful critical care pharmacy services require attention to multiple facets, including basic operations, staff development, and protocol implementation.
- Patient safety, training programs, and research are integral to advanced services.
Conclusions:
- Developing robust critical care pharmacy services is vital for optimizing care in intensive care settings.
- A structured approach encompassing service establishment, professional growth, and research is recommended.
More Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...